Patients with Atypical Femur Fractures Have the Same Mortality as the Background Population - Drug-Channeling Bias, Bisphosphonate Effects, and Public Health Implications

Bo Abrahamsen; Daniel Prieto-Alhambra

doi:10.1002/jbmr.2801

Patients with Atypical Femur Fractures Have the Same Mortality as the Background Population - Drug-Channeling Bias, Bisphosphonate Effects, and Public Health Implications

Bo Abrahamsen^*, Daniel Prieto-Alhambra

^*Corresponding author af dette arbejde

Medicinsk Afdeling

Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning

Originalsprog	Engelsk
Sider (fra-til)	488-490
Antal sider	3
Tidsskrift	Journal of Bone and Mineral Research
Vol/bind	31
Udgave nummer	3
DOI	https://doi.org/10.1002/jbmr.2801
Status	Udgivet - 1 mar. 2016

Adgang til dokumentet

10.1002/jbmr.2801

Andre filer og links

http://www.scopus.com/inward/record.url?scp=84962784412&partnerID=8YFLogxK

Citationsformater

@article{a1737248961843a3a0497cdaadcac1cf,

title = "Patients with Atypical Femur Fractures Have the Same Mortality as the Background Population - Drug-Channeling Bias, Bisphosphonate Effects, and Public Health Implications",

author = "Bo Abrahamsen and Daniel Prieto-Alhambra",

year = "2016",

month = mar,

day = "1",

doi = "10.1002/jbmr.2801",

language = "English",

volume = "31",

pages = "488--490",

journal = "Journal of Bone and Mineral Research",

issn = "0884-0431",

publisher = "Wiley-Blackwell",

number = "3",

}

TY - JOUR

T1 - Patients with Atypical Femur Fractures Have the Same Mortality as the Background Population - Drug-Channeling Bias, Bisphosphonate Effects, and Public Health Implications

AU - Abrahamsen, Bo

AU - Prieto-Alhambra, Daniel

PY - 2016/3/1

Y1 - 2016/3/1

UR - http://www.scopus.com/inward/record.url?scp=84962784412&partnerID=8YFLogxK

U2 - 10.1002/jbmr.2801

DO - 10.1002/jbmr.2801

M3 - Comment/debate

C2 - 26840991

AN - SCOPUS:84962784412

SN - 0884-0431

VL - 31

SP - 488

EP - 490

JO - Journal of Bone and Mineral Research

JF - Journal of Bone and Mineral Research

IS - 3

ER -